Agf Investments LLC Novavax Inc Transaction History

Agf Investments LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$121.0 - $257.67 $314,600 - $669,942	-2,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $652,120 - $1.85 Million	-5,772 Reduced 68.94%	2,600 $471,000
Q4 2020 Feb 08, 2021	BUY	$78.74 - $139.5 $659,211 - $1.17 Million	8,372 New	8,372 $934,000

291

93.3M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $573M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.